Peptide-Based Vaccination Therapy for Rheumatic Diseases
Rheumatic diseases are extremely heterogeneous diseases with substantial risks of morbidity and mortality, and there is a pressing need in developing more safe and cost-effective treatment strategies. Peptide-based vaccination is a highly desirable strategy in treating noninfection diseases, such as...
Saved in:
Main Authors: | Bin Wang, Shiju Chen, Qing Zheng, Yuan Liu, Guixiu Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2020/8060375 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cellular therapies in rheumatic and musculoskeletal diseases
by: Pedro Franco-Fuquen, et al.
Published: (2025-06-01) -
Safety of Cyclophosphamide Therapy in Autoimmune Rheumatic Diseases
by: Ramaswamy Subramanian, et al.
Published: (2019-01-01) -
Immunological Changes in Peripheral Blood of Ankylosing Spondylitis Patients during Anti-TNF-α Therapy and Their Correlations with Treatment Outcomes
by: Rongjuan Chen, et al.
Published: (2021-01-01) -
Towards a Vaccine Against Rheumatic Fever
by: L. Guilherme, et al.
Published: (2006-01-01) -
Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume II
by: Katarzyna Bogunia-Kubik, et al.
Published: (2025-01-01)